High Throughput Process Development

High Throughput Process Development Market Outlook

The global high throughput process development market was valued at approximately USD 5.3 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of around 8.2%, reaching nearly USD 10.1 billion by 2035. This robust growth is attributed to the increasing demand for efficient drug discovery processes, advancements in automation and technology, and the rising prevalence of chronic diseases that necessitate rapid and effective therapeutic solutions. Furthermore, the pharmaceutical and biotechnology sectors are heavily investing in research and development (R&D) to enhance their product pipelines, which is driving the demand for high throughput methodologies. The growing emphasis on personalized medicine and the need for innovative therapeutic approaches further bolster the market growth, as these methodologies enable rapid testing of numerous compounds in parallel, thereby accelerating the discovery process.

Growth Factor of the Market

The high throughput process development market is experiencing significant growth due to several key factors. The ever-increasing pace of drug discovery, coupled with the need for cost-effective and time-efficient processes, is pushing pharmaceutical companies to adopt high throughput techniques. These methods facilitate the rapid analysis of vast libraries of compounds and biological samples, significantly improving the efficiency of R&D activities. Additionally, the integration of advanced technologies such as microfluidics and automation systems is enhancing the throughput and reliability of experiments, making it easier for researchers to gather data quickly. Furthermore, with the rise in chronic diseases and the subsequent demand for new drugs, the pharmaceutical industry is under pressure to innovate and expedite the drug discovery process. The increasing adoption of personalized medicine is also a contributing factor, as high throughput technologies enable the screening of compounds tailored to specific patient needs. Lastly, ongoing collaborations between academic institutions and industry players are further fostering innovation in high throughput process development.

Key Highlights of the Market

• The market is projected to grow at a CAGR of 8.2% from 2023 to 2035.
• Pharmaceutical and biotechnology companies are the largest end-users, driving significant investment in high throughput technologies.
• Microfluidics technology is anticipated to dominate the technology segment due to its efficiency and precision.
• North America holds the largest market share, accounting for over 45% of the global market due to strong R&D activities.
• Rapid advancements in automation and AI integration are enhancing the capabilities of high throughput processes.

By Product Type

Consumables:

The consumables segment is a vital component of the high throughput process development market, as it encompasses various materials required for conducting experiments. This includes reagents, assay plates, and other laboratory supplies that are indispensable in high throughput screening (HTS) environments. The demand for consumables is driven primarily by the increasing number of experiments being conducted in drug discovery and bioprocess development. As more pharmaceutical companies and research institutions adopt high throughput methodologies, the consumption of these materials rises, thus contributing significantly to the market's overall growth. Furthermore, advancements in consumable technology, such as improved assay plates designed for specific assays, are enhancing efficiency and accuracy, further boosting demand.

Instruments:

Instruments are a critical segment in the high throughput process development market, encompassing a range of sophisticated equipment essential for conducting high throughput assays and experiments. This includes robotic systems, automated liquid handling systems, and analytical instruments capable of processing large sets of samples quickly and accurately. The growth of this segment is fueled by the ongoing advancements in automation and robotics, which have significantly reduced the time and labor involved in experimental procedures. Additionally, the trend toward miniaturization in laboratory instruments is enabling researchers to perform experiments with minimal sample volumes while maintaining high throughput levels. As companies increasingly focus on efficiency and speed in drug development, the demand for advanced instruments is expected to continue rising.

Software:

The software segment in the high throughput process development market plays a pivotal role in managing, analyzing, and interpreting the vast amounts of data generated during experiments. This includes data management systems, analytical software, and laboratory information management systems (LIMS) designed specifically for high throughput environments. The demand for sophisticated software solutions is increasing as researchers seek to streamline their workflows and improve data accuracy. Additionally, the integration of artificial intelligence and machine learning algorithms in software applications is enhancing data analysis capabilities, allowing for quicker decision-making in the drug discovery process. As a result, the software segment is poised for substantial growth, driven by the need for comprehensive data management solutions in high throughput environments.

Services:

The services segment encompasses a variety of support offerings such as consulting, training, and maintenance services for high throughput process development. As more organizations adopt these technologies, the need for specialized services to optimize their use becomes increasingly important. Consulting services, in particular, are in high demand as they provide expertise in implementing high throughput strategies tailored to specific research needs. Additionally, training services are essential to ensure that personnel are equipped with the necessary skills to operate complex high throughput systems effectively. This segment is expected to grow significantly, driven by the increasing complexity of high throughput methodologies and the need for ongoing support to maximize operational efficiency.

Accessories:

Accessories, which include additional tools and equipment that complement the primary instruments and consumables, represent a niche but important segment of the high throughput process development market. This can range from specialized pipette tips to microplate readers and other ancillary devices that enhance the functionality and efficiency of high throughput workflows. The growth of this segment is linked to the expansion of high throughput activities across various research sectors, prompting the need for compatible accessories that ensure optimal performance of the primary equipment. As laboratories continue to scale their operations and embrace high throughput methodologies, the demand for a wide array of accessories is expected to increase, contributing to the overall market growth.

By Application

Drug Discovery:

The drug discovery application segment is the most significant contributor to the high throughput process development market, as it encompasses the initial stages of pharmaceutical research where potential drug candidates are identified and evaluated. The necessity for rapid screening of numerous compounds to find viable drug candidates has led to the widespread adoption of high throughput screening technologies. The growing prevalence of diseases and the urgent need for new therapeutic agents are driving pharmaceutical companies to invest heavily in drug discovery initiatives. Moreover, the integration of high throughput strategies allows for the efficient evaluation of drug-like properties, improving the chances of discovering effective treatments while reducing time and costs associated with the traditional discovery processes.

Bioprocess Development:

Bioprocess development is another crucial application area within the high throughput process development market, focusing on the production of biological products, including vaccines, antibodies, and recombinant proteins. The increasing demand for biologics, driven by their effectiveness in treating various diseases, is fostering growth in this segment. High throughput technologies enable faster and more efficient optimization of bioprocess parameters, such as cell culture conditions and protein purification processes. As biopharmaceutical companies seek to streamline their production workflows and enhance yield while minimizing costs, the adoption of high throughput approaches in bioprocess development is expected to gain momentum, contributing significantly to market growth.

Bioanalytical Testing:

Bioanalytical testing, which involves the qualitative and quantitative analysis of drugs and their metabolites in biological samples, is a growing application area for high throughput process development. The increasing regulatory requirements for the assessment of drug safety and efficacy, coupled with the need for rapid analysis, are driving the demand for high throughput bioanalytical testing methodologies. These techniques enable laboratories to process a high volume of samples efficiently, providing timely results that are critical for advancing drug development. Additionally, the ongoing advancements in analytical technologies are enhancing the accuracy and sensitivity of bioanalytical tests, further propelling the growth of this segment within the high throughput process development market.

Other:

The "Other" application segment comprises various niche applications that leverage high throughput methodologies for different purposes, such as environmental testing, food safety analysis, and agricultural research. Although smaller in scope compared to the primary applications, this segment is gaining traction as industries increasingly recognize the value of high throughput techniques for enhancing efficiency and accuracy in testing. The growing emphasis on quality control and regulatory compliance across sectors is also driving the adoption of high throughput processes for testing and analysis, contributing to the overall growth of the market.

By User

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies represent the largest user segment within the high throughput process development market, as they are the primary drivers of innovation in drug discovery and development. These companies are increasingly adopting high throughput methodologies to streamline their R&D processes, enabling them to identify potential drug candidates more rapidly and cost-effectively. The competitive landscape in the pharmaceutical industry compels companies to expedite time-to-market for new drugs, making high throughput technologies essential for meeting these demands. Furthermore, the growing trend of personalized medicine is prompting these companies to utilize high throughput techniques for more tailored approaches in drug development, further fueling market growth.

Contract Research Organizations:

Contract Research Organizations (CROs) play a significant role in the high throughput process development market, providing specialized services to pharmaceutical and biotechnology companies. These organizations often have extensive expertise and resources dedicated to high throughput technologies, allowing them to offer comprehensive solutions for drug discovery and development. By leveraging high throughput methodologies, CROs can enhance operational efficiency, reduce lead times, and deliver high-quality data to their clients. As the demand for outsourcing R&D activities continues to grow, CROs are increasingly adopting high throughput processes to cater to the needs of their clients, thereby contributing to the overall growth of the market.

Academic & Research Institutes:

Academic and research institutes are increasingly recognizing the value of high throughput process development methodologies in advancing scientific research and innovation. These institutions are leveraging high throughput technologies to facilitate a wide range of studies, from drug discovery to basic biological research. The ability to perform large-scale experiments efficiently is critical for researchers seeking to uncover new insights and technologies. Furthermore, collaborations between academic institutions and industry partners are fostering the adoption of high throughput approaches in research settings, enabling a more dynamic exchange of knowledge and resources. This growing interest from the academic sector is expected to contribute positively to the overall market landscape.

Others:

The "Others" user segment encompasses various entities, including government research laboratories and nonprofit organizations that utilize high throughput process development methodologies for diverse applications. These organizations may engage in research that addresses public health concerns, environmental issues, or other scientific inquiries that benefit from high throughput techniques. As awareness of the advantages of high throughput methodologies grows, these institutions are increasingly integrating such approaches into their research frameworks. This trend is anticipated to bolster the market, as these organizations seek innovative solutions to address pressing challenges.

By Technology

Microfluidics:

Microfluidics technology is at the forefront of the high throughput process development market, enabling the manipulation of small volumes of fluids in micro-scale environments. This technology allows researchers to conduct numerous experiments in parallel with minimal sample usage, significantly enhancing efficiency and reducing costs. The rapid development of microfluidics has led to the creation of various applications, including drug screening, diagnostic testing, and the study of cellular behavior. As the demand for precise and efficient methods in biological research continues to grow, the microfluidics segment is expected to experience substantial growth, further solidifying its position in the high throughput process development landscape.

Lab-on-a-Chip:

Lab-on-a-chip technology integrates multiple laboratory functions onto a single chip, allowing for the miniaturization and automation of complex biological assays. This technology is particularly beneficial in high throughput settings, where it enables rapid analysis of samples with minimal reagent consumption. The increasing focus on personalized medicine and point-of-care diagnostics is driving the adoption of lab-on-a-chip solutions, as they provide timely results that facilitate better clinical decision-making. As researchers and clinicians seek more efficient ways to conduct assays, the lab-on-a-chip segment is poised for significant growth in the high throughput process development market.

High-Content Screening:

High-content screening (HCS) is a sophisticated technique that combines high throughput technologies with advanced imaging and analysis to evaluate multiple parameters in cells or tissues simultaneously. This approach allows researchers to gather comprehensive data about cellular responses to various compounds, enabling the identification of potential drug candidates with greater accuracy. The increasing complexity of biological systems and the need for detailed analysis in drug discovery are driving the demand for HCS technologies. As pharmaceutical companies continue to prioritize the identification of effective therapeutic agents, the HCS segment is expected to witness robust growth in the high throughput process development market.

Parallel Synthesis:

Parallel synthesis is a critical technology in high throughput process development, allowing researchers to synthesize multiple compounds simultaneously under controlled conditions. This approach accelerates the drug discovery process by enabling rapid generation and screening of diverse chemical libraries. As the pharmaceutical and biotechnology industries strive to enhance their R&D efficiency and discover new therapeutic candidates, parallel synthesis technologies are becoming increasingly important. The ongoing advancements in this field, including automation and robotics, are expected to drive significant growth in the parallel synthesis segment, contributing to the overall expansion of the high throughput process development market.

Others:

The "Others" technology segment includes various emerging technologies and methodologies that support high throughput process development. This may encompass novel assay techniques, data analysis tools, and innovative laboratory equipment designed to enhance the efficiency and accuracy of high throughput experiments. As research continues to evolve and new technologies are developed, this segment is anticipated to grow, driven by the demand for improved capabilities in drug discovery and other applications. The continual integration of cutting-edge technologies will play a crucial role in shaping the future of high throughput process development.

By Region

The North American region holds a dominant position in the high throughput process development market, accounting for more than 45% of the global market share in 2023. This can be attributed to the presence of major pharmaceutical and biotechnology companies, a robust research ecosystem, and significant investments in R&D activities. The United States, in particular, is a hub for innovation in drug discovery, driving demand for high throughput methodologies. Furthermore, the region benefits from advanced infrastructure and a strong regulatory framework that supports the adoption of new technologies. As the demand for efficient drug development processes continues to rise, North America is expected to maintain its leading position in the market, with a projected CAGR of 8.5% over the forecast period.

Europe is another key region in the high throughput process development market, accounting for approximately 30% of the global market in 2023. The European market is characterized by a strong emphasis on research and innovation, with numerous academic institutions and biotechnology firms actively engaged in high throughput research initiatives. Additionally, the increasing focus on personalized medicine and the rising prevalence of chronic diseases are driving the demand for high throughput methodologies across the region. The collaborative efforts between academia and industry players are further enhancing the growth prospects in Europe, with a projected CAGR of 7.8% through 2035.

Opportunities

The high throughput process development market presents numerous opportunities for growth, particularly in the realm of technology integration. As advancements in automation, artificial intelligence, and data analytics continue to evolve, there is an immense potential for enhancing the capabilities of high throughput methodologies. The integration of AI and machine learning algorithms into high throughput screening processes can significantly improve data analysis, enabling researchers to identify promising drug candidates more quickly and accurately. This technological evolution not only accelerates the drug discovery process but also enhances the overall productivity and efficiency of R&D activities. Furthermore, the ongoing trend towards personalized medicine and targeted therapies is creating new avenues for high throughput methodologies to deliver tailored solutions that meet specific patient needs, thus expanding the market reach.

Another significant opportunity lies in the expanding global market for biologics and biosimilars. As the demand for these products continues to grow, pharmaceutical and biotechnology companies are increasingly turning to high throughput process development techniques to streamline their R&D processes and optimize bioprocesses. This shift is particularly relevant in the context of vaccine development and the production of monoclonal antibodies, where high throughput methodologies can be leveraged to enhance productivity and reduce costs. Additionally, the rising trend of outsourcing R&D activities to Contract Research Organizations (CROs) further amplifies the opportunities for high throughput process development, as these organizations seek to meet the growing demands of their clients through efficient and innovative solutions.

Threats

Despite the promising growth prospects in the high throughput process development market, several threats could hinder its progress. One of the primary challenges is the high costs associated with implementing and maintaining advanced high throughput technologies. For many smaller pharmaceutical companies and research institutions, the investment required to acquire sophisticated instruments, software, and consumables may be prohibitive. As a result, these organizations may struggle to adopt high throughput methodologies, limiting their competitiveness in the market. Additionally, the rapid pace of technological advancement can pose a threat, as organizations may find it challenging to keep up with the latest innovations and upgrades. This could lead to a reliance on outdated technologies, hindering operational efficiency and ultimately affecting the quality of research outcomes.

Another potential threat to the high throughput process development market is the increasing regulatory scrutiny surrounding drug discovery and development processes. Regulatory bodies are placing greater emphasis on data integrity, reproducibility, and compliance, which can present challenges for organizations seeking to implement high throughput methodologies. The complexity of ensuring compliance with these regulations can lead to delays in research timelines and increased operational costs. Furthermore, the growing concern over the reliability of data generated through high throughput techniques may raise questions about the validity of results, further complicating the regulatory landscape. These challenges require organizations to invest in comprehensive quality assurance measures and constant monitoring, which can strain resources and hinder market growth.

Competitor Outlook

• Thermo Fisher Scientific
• Agilent Technologies
• PerkinElmer
• BD Biosciences
• Corning Incorporated
• Danaher Corporation
• Brookhaven Instruments Corporation
• Biotek Instruments
• Hudson Robotics
• Berthold Technologies
• Eppendorf AG
• Sartorius AG
• Illumina Inc.
• QIAGEN
• MilliporeSigma

The competitive landscape of the high throughput process development market is characterized by a diverse range of players, including large multinational corporations, specialized technology providers, and emerging companies. Major players such as Thermo Fisher Scientific, Agilent Technologies, and PerkinElmer dominate the market due to their extensive portfolios of high throughput technologies, instruments, and services. These companies invest heavily in research and development to enhance their product offerings and maintain a competitive edge, focusing on innovation and customer-centric solutions. Additionally, partnerships and collaborations among key players are common, enabling them to leverage each other's strengths and expand their market presence.

Emerging companies and startups are also making their mark in the high throughput process development market by offering niche solutions and specialized technologies. These players often focus on innovative approaches to streamline high throughput processes, catering to specific needs within the pharmaceutical and biotechnology sectors. As these companies continue to develop cutting-edge technologies, they contribute to the overall dynamism of the market, fostering a culture of innovation and competition. The increasing trend of acquisitions and mergers among established players and startups is further reshaping the competitive landscape, with companies seeking to enhance their capabilities and broaden their service offerings.

Some of the major companies, such as BD Biosciences and Corning Incorporated, are investing significantly in advanced technologies to expand their high throughput capabilities. BD Biosciences, known for its expertise in biosciences and biotechnology, is focusing on the development of high throughput instruments and reagents that enhance the efficiency of drug discovery processes. Similarly, Corning Incorporated leverages its expertise in material science to develop innovative consumables and laboratory accessories that support high throughput methodologies. As these companies continue to evolve and adapt to changing market dynamics, they play a crucial role in shaping the future of high throughput process development.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 QIAGEN
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 PerkinElmer
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Eppendorf AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Sartorius AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Illumina Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 BD Biosciences
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 MilliporeSigma
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Hudson Robotics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Biotek Instruments
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Danaher Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Corning Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Berthold Technologies
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Brookhaven Instruments Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 High Throughput Process Development Market, By User
    • 6.1.1 Pharmaceutical & Biotechnology Companies
    • 6.1.2 Contract Research Organizations
    • 6.1.3 Academic & Research Institutes
    • 6.1.4 Others
  • 6.2 High Throughput Process Development Market, By Technology
    • 6.2.1 Microfluidics
    • 6.2.2 Lab-on-a-Chip
    • 6.2.3 High-Content Screening
    • 6.2.4 Parallel Synthesis
    • 6.2.5 Others
  • 6.3 High Throughput Process Development Market, By Application
    • 6.3.1 Drug Discovery
    • 6.3.2 Bioprocess Development
    • 6.3.3 Bioanalytical Testing
    • 6.3.4 Other
  • 6.4 High Throughput Process Development Market, By Product Type
    • 6.4.1 Consumables
    • 6.4.2 Instruments
    • 6.4.3 Software
    • 6.4.4 Services
    • 6.4.5 Accessories

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 High Throughput Process Development Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global High Throughput Process Development market is categorized based on

By Product Type

• Consumables
• Instruments
• Software
• Services
• Accessories

By Application

• Drug Discovery
• Bioprocess Development
• Bioanalytical Testing
• Other

By User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes
• Others

By Technology

• Microfluidics
• Lab-on-a-Chip
• High-Content Screening
• Parallel Synthesis
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Agilent Technologies
• PerkinElmer
• BD Biosciences
• Corning Incorporated
• Danaher Corporation
• Brookhaven Instruments Corporation
• Biotek Instruments
• Hudson Robotics
• Berthold Technologies
• Eppendorf AG
• Sartorius AG
• Illumina Inc.
• QIAGEN
• MilliporeSigma